Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian Rapid Treatment Center of Excellence.
CNS Spectr
; 27(3): 322-330, 2022 06.
Article
in En
| MEDLINE
| ID: mdl-33267928
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Bipolar Disorder
/
Depressive Disorder, Major
/
Depressive Disorder, Treatment-Resistant
/
Ketamine
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
CNS Spectr
Journal subject:
NEUROLOGIA
Year:
2022
Document type:
Article
Affiliation country: